RB Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $313K | Hold |
2,471
| – | – | 0.07% | 149 |
|
|
2025
Q1 | $316K | Hold |
2,471
| – | – | 0.07% | 140 |
|
|
2024
Q4 | $327K | Buy |
2,471
+1
| +0% | +$132 | 0.07% | 140 |
|
|
2024
Q3 | $360K | Buy |
2,470
+1
| +0% | +$146 | 0.08% | 134 |
|
|
2024
Q2 | $339K | Hold |
2,469
| – | – | 0.08% | 136 |
|
|
2024
Q1 | $339K | Buy |
2,469
+1
| +0% | +$137 | 0.09% | 141 |
|
|
2023
Q4 | $335K | Buy |
2,468
+1
| +0% | +$136 | 0.1% | 133 |
|
|
2023
Q3 | $302K | Hold |
2,467
| – | – | 0.09% | 135 |
|
|
2023
Q2 | $313K | Hold |
2,467
| – | – | 0.09% | 136 |
|
|
2023
Q1 | $319K | Sell |
2,467
-51
| -2% | -$6.59K | 0.1% | 138 |
|
|
2022
Q4 | $331K | Buy |
2,518
+54
| +2% | +$7.09K | 0.12% | 131 |
|
|
2022
Q3 | $288K | Sell |
2,464
-20
| -0.8% | -$2.34K | 0.11% | 133 |
|
|
2022
Q2 | $292K | Hold |
2,484
| – | – | 0.11% | 139 |
|
|
2022
Q1 | $324K | Buy |
2,484
+1
| +0% | +$130 | 0.1% | 134 |
|
|
2021
Q4 | $379K | Hold |
2,483
| – | – | 0.12% | 127 |
|
|
2021
Q3 | $401K | Hold |
2,483
| – | – | 0.15% | 117 |
|
|
2021
Q2 | $406K | Buy |
2,483
+1
| +0% | +$164 | 0.15% | 115 |
|
|
2021
Q1 | $374K | Hold |
2,482
| – | – | 0.17% | 109 |
|
|
2020
Q4 | $376K | Sell |
2,482
-279
| -10% | -$42.3K | 0.17% | 102 |
|
|
2020
Q3 | $385K | Buy |
2,761
+100
| +4% | +$13.9K | 0.18% | 98 |
|
|
2020
Q2 | $364K | Buy |
2,661
+1
| +0% | +$137 | 0.19% | 98 |
|
|
2020
Q1 | $287K | Sell |
2,660
-7,542
| -74% | -$814K | 0.18% | 97 |
|
|
2019
Q4 | $220K | Buy |
+10,202
| New | +$220K | 0.13% | 122 |
|